Market News AIOpen the app

SLN stock news · Silence Therapeutics plc

Stories about Silence Therapeutics plc (SLN) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for SLN

Follow Silence Therapeutics plc (SLN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SLN
Free on the App Store and Google Play, or on the web.
  1. Oct 23, 2026, 4:22 AM ET · Deal

    Halper Sadeh LLC is looking into Merck KGaA's plan to buy Silence Therapeutics plc.

    Neutral

    Silence Therapeutics faces a law firm's review of Merck's proposed $20-per-ADS cash offer. No finding or deal change is reported, so the story does not shift its outlook.

  2. Oct 19, 2026, 1:17 PM ET · Market

    12 health care companies are seeing big changes in their stock prices today.

    Neutral

    Silence Therapeutics shares rose 125.6% on Monday, but the article gives no company news explaining why. The move alone does not change the company's outlook.

  3. Oct 19, 2026, 10:13 AM ET · Market

    Silence Therapeutics, Disc Medicine, Veradermics, and other major stocks jumped up on Monday.

    Good for SLN

    Silence Therapeutics agreed to be bought by Merck for cash. The stated $20 payment per ADS supports a favorable reading of the deal.